Health Condition 1: D500- Iron deficiency anemia secondary to blood loss (chronic) Health Condition 2: D508- Other iron deficiency anemias
Conditions
Interventions
Intervention1: Injection Ferric Carboxymaltose:
We will be studying the safety,efficacy,cost analysis and acceptability of Intravenous Ferric Carboxymaltose for treatment of Iron deficiency anemia.It
Sponsors
AIIMS Guwahati
Eligibility
Inclusion criteria
Inclusion criteria: 1. All patients = 18 years of age with confirmed diagnosis of Iron deficiency anemia 2. Those who have given consent
Exclusion criteria
Exclusion criteria: 1. Patients with previous history of hypersensitivity reaction to any of the parenteral iron products 2. Pregnant females 3. Patients with concurrent Vitamin B12 deficiency
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cost analysis of Intravenous Ferric Carboxymaltose for treatment of Iron deficiency anemia in a tertiary care centreTimepoint: Data collection at 2 time points: 1) At the time of diagnosis 2) Assessment of therapeutic response 1 month after the first dose of Injection Ferric Carboxymaltose | — |
Secondary
| Measure | Time frame |
|---|---|
| Safety, efficacy and acceptability of Intravenous Ferric Carboxymaltose for treatment of Iron deficiency anemia in a tertiary care centreTimepoint: Data collection at 2 time points: 1) At the time of diagnosis 2) Assessment of therapeutic response 1 month after the first dose of Injection Ferric Carboxymaltose | — |
Countries
India
Contacts
Public ContactRituparna Chetia
All India Institute of Medical Sciences (AIIMS),Guwahati
Outcome results
None listed